Viewing Study NCT02182232


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-27 @ 8:36 AM
Study NCT ID: NCT02182232
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2014-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2014-07-02
First Submit QC Date: None
Study First Post Date: 2014-07-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-17
Last Update Post Date: 2014-07-18
Last Update Post Date Type: ESTIMATED